Norvane20 / 32
Pillar · survival
Compliance: the section you don't skip
Two sample ads. One obvious, one with a single bad line. Both stopped.
- Behind the stamps: two made-up sample ads, each failed by the research-use rules.
- This section covers the scanner, the verdict, the research-use rewrite, the re-scan, the check with the AI unavailable, the explicit error, the site scan and the audit log.
- The rules check five things: compound names, benefit claims, dosing, "low-profile" wording, and the research-use line.
- No certification is claimed.
Research-use check firstThe AI can't overrule a findingEvery run audited
REJECTEDMade-up sample ads
Research-use peptide sales · LastStop OS · sample data20 / 32
Norvane21 / 32
21ClaimRight / Compliance
The scanner reads the whole ad
Text in the image is readFive research-use checksExact words quoted
- The sample ad names a compound, promises a benefit and gives a daily dose, in the picture and in the caption.
- The checklist is the research-use rule set: compound, benefit, dosing, low-profile, research-use line. Each is ticked or flagged from the real findings.
- Each finding names the rule and quotes the exact words.
- The rules decide. The AI reads the text in the image and cannot overrule a finding.
It reads the words in the picture too, and names the rule each one breaks.
Research-use peptide sales · LastStop OS · sample data21 / 32
Norvane22 / 32
22ClaimRight / Compliance
The verdict
6 blocking · 1 warningA fix for each finding"Rescue this ad"
- Seven findings, six blocking and one warning, each with a research-use fix.
- Then FAIL, and a button to rescue the ad.
- The dosing line an earlier version of the scanner missed is caught here.
- A second review agreed: FAIL.
Seven findings, six blocking. FAIL, with a way out.
Research-use peptide sales · LastStop OS · sample data22 / 32
Norvane23 / 32
23ClaimRight / Compliance
Fix a flagged ad
Before and afterNo compound, benefit or doseResearch-use line added
- Before: the failed ad and its findings. After: the rewrite of the same ad.
- No compound name, no benefit, no dosing. The app adds the research-use line itself.
- The note on screen: "Checked against the research-use rules before showing."
- A person decides whether to use it.
The same ad, rewritten to the research-use rules, and checked before you see it.
Research-use peptide sales · LastStop OS · sample data23 / 32
Norvane24 / 32
24ClaimRight / Compliance
Re-scan: FAILED to PASSED
Same rules both timesRewrite composited on a pictureLabelled stand-in picture
- The rescued ad is scanned again with the same rules: before FAILED, after PASSED.
- The rewrite is set onto a new background by code.
- The background in this capture is a labelled SAMPLE IMAGE stand-in, because the image generator was not called. The copy, its check and the verdict are real.
Before: FAILED. After: PASSED. Same scanner, same rules.
Research-use peptide sales · LastStop OS · sample data24 / 32
Norvane25 / 32
25ClaimRight / Compliance
The check holds if the AI is down
AI service off for this testVerdict: FAILShown as proof, not the normal state
- The same bad ad, with the AI service switched off for this test: the research-use check still fails it.
- The check keeps working if the AI service is down.
- This is shown to prove the point. It is not the normal running state.
If the AI service is down, the bad ad still fails.
Research-use peptide sales · LastStop OS · sample data25 / 32
Norvane26 / 32
26ClaimRight / Compliance
When nothing safe is left, it says so
Explicit errorNo filler resultEdit manually
- With the AI unavailable and nothing safe left in the ad, the answer is: "Couldn't produce a research-use-safe rewrite — edit manually."
- No fixed-up result is shown. A weak ad shown as finished would teach the operator the tool is weak.
No safe rewrite? You get an error, not a watered-down ad.
Research-use peptide sales · LastStop OS · sample data26 / 32
Norvane27 / 32
27ClaimRight / Compliance
One bad line, removed by the rules
One flagged lineGood lines keptLabelled as a rules rewrite
- A second sample ad with one bad line (a weight-loss claim): two findings, FAIL.
- Its rewrite while the AI is unavailable: the rules remove the bad clause, keep and join the good lines, and the app adds the research-use line.
- Labelled on screen: "Rewritten by the research-use rules (AI unavailable)".
One bad line out, the good lines kept, the research-use line added.
Research-use peptide sales · LastStop OS · sample data27 / 32
Norvane28 / 32
28ClaimRight / Compliance
Site scan
Nine blockersNamed by ruleResearch-use line warning
- Site scan of a made-up sample product page: production Fail.
- Nine blockers named by rule (compound, benefit, dosing, low-profile), plus a warning for the missing research-use line.
- The same rules as the ad scanner, so a page and an ad are held to one standard.
Paste a product page. Every blocker named by rule.
Research-use peptide sales · LastStop OS · sample data28 / 32
Norvane29 / 32
29ClaimRight / Compliance
A clean page passes
Certificate of analysis linkedResearch-use line presentProduction pass
- A clean sample page, with a certificate of analysis and the research-use line: production pass.
- Passing is a rules result, not a certification.
A page with its COA and the research-use line passes.
Research-use peptide sales · LastStop OS · sample data29 / 32
Norvane30 / 32
30ClaimRight / Compliance
Every run, in the audit log
Scanner, rewrite, site scanRefusals logged tooShort quoted words
- Each row: who ran it, the module, the verdict, the rules hit and a short quote of the words.
- A refused rewrite is logged like any other run.
- It is the evidence to show when a payment processor or ad platform reviews the store.
Every scan, rewrite and site scan leaves a row: who, what, verdict, rule.
Research-use peptide sales · LastStop OS · sample data30 / 32
